Understanding Antiphospholipid Syndrome

Antiphospholipid syndrome (APS) is an autoimmune thrombo-inflammatory disorder characterized by a spectrum of clinical manifestations, including blood clotting complications and thrombocytopenia. Early diagnosis and personalized treatment are hampered by a lack of clinically actionable biomarkers for various symptoms associated with APS. Enhanced biomarkers are essential for timely detection of complications, allowing for improved risk assessment and management strategies for patients with APS. This progressive understanding is crucial for advancing therapeutic approaches to mitigate the effects of this complex disease.